El Salvador - Active Management of the Third Stage of Labor - POPPHI
El Salvador - Active Management of the Third Stage of Labor - POPPHI
El Salvador - Active Management of the Third Stage of Labor - POPPHI
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
ased on current consumption <strong>of</strong> oxytocin. Given that only 60 percent <strong>of</strong> women receivedoxytocin during <strong>the</strong> third or fourth stages <strong>of</strong> labor, this excess stock should be used to expand <strong>the</strong>use <strong>of</strong> AMTSL for all deliveries. Ergometrine was available at <strong>the</strong> time <strong>of</strong> visit in 90 percent <strong>of</strong><strong>the</strong> facilities, and among <strong>the</strong>se facilities, ten percent had experienced a recent stockout. For fivepercent <strong>of</strong> <strong>the</strong>se facilities, <strong>the</strong> stockout lasted 30 days or longer. One-third <strong>of</strong> <strong>the</strong>se facilities hada stock <strong>of</strong> ergometrine sufficient for greater than 12 months, based on current consumption.Misoprostol is <strong>the</strong> uterotonic drug <strong>the</strong> least available in <strong>El</strong> <strong>Salvador</strong>, with only in 64 percent <strong>of</strong><strong>the</strong> facilities that usually procure it. In more than one-third <strong>of</strong> <strong>the</strong>se facilities (36 percent), <strong>the</strong>rehad been stockouts <strong>of</strong> misprostol during <strong>the</strong> three previous months. Of <strong>the</strong> 22 hospitals thatprocure misoprostol, 27 percent had stock on hand sufficient for longer than 12 months.Table 3.4. Percent <strong>of</strong> facilities procuring oxytocin, ergometrine and misoprostol by costsand stock <strong>of</strong> uterotonic drugs% <strong>of</strong> facilitiesn = 28Conditions Oxytocin Ergometrine MisoprostolProcured by <strong>the</strong> institution 100.0 75.0 78.6% <strong>of</strong> facilitiesn =28 n =21 n =22Availability at <strong>the</strong> time <strong>of</strong> <strong>the</strong> visit 100.0 90.5 63.6How is quantity <strong>of</strong> drug determined forprocurementBased on consumption 96.4 90.4 91.0Standard/fixed quantity3.6 4.8 4.5(determined at <strong>the</strong> central level)No information 0.0 4.8 4.5Facility’s procurement price perampoule/tablet in US$= 7.00 0.0 0.0 18.2No information 7.1 14.3 18.2Months covered with available stockNone available at visit 0.0 0.0 36.4< 1 Month 21.4 9.5 0.01-